Integrated Diabetes Care

Time-In-Range (TIR): How to interpret it and how it is associated with outcomes

What Is Time-in-Range?

Insulin advancement in Type 2 diabetes: Unmet needs with commonly-used options

The InRange Study

EVOLUTION: RWE from Saudi Arabia

EMPOWER Study in Saudi Arabia

Do historical HbA1c values explain glycemic legacy effect in type 2 diabetes?

Diabetes your type: Testimonial by Dr. Nadia

Diabetes your type: Testimonial by Dr. Hussein​

Diabetes Your Type: Testimonial by Dr. Bassam​

Expert consensus statement on management of older adults with type 2 diabetes (T2D)

Challenges associated with commonly-used insulin advancement options

ATTD 2021: Patients’ profiles for digital tools

Unveiling Significance of Time in Range: Value as key Glycemic Biomarker

Understanding Time-in-Range: Assessment, Targets, and Benefits for Optimal Glycemic Control

Time-in-Range: A Key Determinant of Quality of Life

The value of Time-in-range

The Evolving Role of Treatment and Technology in Diabetes Care

Impact of Time-In-Range on Diabetes Management

Need to redefine the treatment paradigm Post OAD

Groundbreaking SoliD Study: Comparative Efficacy of iGlarLixi and IDegAsp

Connectivity Canvas: Pioneering Diabetes Management with Connected Insulin Caps

Patient awareness and attainment of goals in Type 2 Diabetes Mellitus: A real-world survey

A narrative review for clinicians on insulin management for Type 2 Diabetes during Ramadan

The Lixilan-L Study

The Bright Study

Reducing risk of severe hypoglycemia - iNPHORM Study

Prevalence of Diabetes in Children and Adolescents

New technologies in Type 2 Diabetes management and future opportunities to improve clinical outcomes

This session emphasizes that new technology in Diabetes management not only can overcome common barriers in achieving glycemic control in people with T2D but also may facilitate more effective and efficient Diabetes care.

Hospitalization Rates for Acute Diabetes Complications Before and After Flash Glucose Monitoring Initiation Among People with Type 1 or Type 2 Diabetes in France: The Relief Study

A Cross-Sectional Analysis of Glycemic Control in Elderly People with Type 2 Diabetes Attending Primary Health Care Unit

Post-exercise hypoglycemia in relation to medication regimen among adults with type 2 diabetes

Management of athletes and active people with diabetes - The American Medical Society for Sports Medicine (AMSSM) scientific statement

Diabetes management during Ramadan